Literature DB >> 19444672

Doubts, denial and divine intervention: understanding delayed attendance and poor retention rates at a HIV treatment programme in rural Tanzania.

Alison Wringe1, Maria Roura, Mark Urassa, Joanna Busza, Veronica Athanas, Basia Zaba.   

Abstract

Irregular or delayed attendance at HIV treatment clinics among HIV-positive individuals can have negative implications for clinical outcomes and may ultimately undermine the effectiveness of national treatment programmes. This study explores factors influencing attendance at HIV clinic appointments among patients in a rural ward in north-west Tanzania. Forty-two in-depth interviews (IDI) and four focus group discussions were conducted with HIV-infected persons who had been referred to a nearby antiretroviral therapy (ART) clinic, and IDI were undertaken with 11 healthcare workers involved in diagnosis, referral and care of HIV-positive patients. The Health Belief Model was applied to explore the role of health-related beliefs and the perceived barriers and benefits associated with regular clinic attendance. Perceived susceptibility to HIV-related illnesses emerged as an important factor influencing clinic attendance, and was often manifest through expressions of acceptance or denial of HIV status and knowledge of HIV disease progression. Denial of HIV status was often associated with using alternative healers, and could occur prior to, during, or after starting ART. Perceptions of illness severity also influenced HIV clinic attendance, and often evolved in relation to changes in physical symptoms. Barriers to clinic attendance frequently included health systems factors, while physical and social benefits encouraged regular clinic attendance. Self-confidence in being able to sustain clinic attendance was often determined by patients' expectations or experiences of family support. These findings suggest that multi-faceted interventions are required to promote regular HIV clinic attendance, including on-going education, counselling and support in both clinic and community settings. These interventions also need to recognise the evolving needs of patients that accompany changes in physical health, and should address local beliefs around HIV aetiology. Decentralisation of HIV services to rural communities should be considered as a priority to redress the balance between perceived barriers to, and benefits of accessing HIV treatment programmes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444672     DOI: 10.1080/09540120802385629

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  45 in total

1.  Identifying Perceived Barriers along the HIV Care Continuum: Findings from Providers, Peer Educators, and Observations of Provider-Patient Interactions in Ethiopia.

Authors:  Sarah Kulkarni; Susie Hoffman; Tsigereda Gadisa; Zenebe Melaku; Mesganaw Fantehun; Muluneh Yigzaw; Wafaa El-Sadr; Robert Remien; Olga Tymejczyk; Denis Nash; Batya Elul
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-07-14

2.  Moderating perceptions of bother reports by individuals experiencing lower urinary tract symptoms.

Authors:  Elizabeth M Botelho; Emily A Elstad; Simone P Taubenberger; Sharon L Tennstedt
Journal:  Qual Health Res       Date:  2011-04-11

3.  A Multilevel Conceptual Framework to Understand the Role of Food Insecurity on Antiretroviral Therapy Adherence in Low-Resource Settings: From Theory to Practice.

Authors:  Rainier Masa; Gina Chowa
Journal:  Soc Work Public Health       Date:  2017-04-03

4.  Health services utilization among South African women living with HIV and reporting sexual and substance-use risk behaviors.

Authors:  Winnie K Luseno; Wendee M Wechsberg; Tracy L Kline; Rachel Middlesteadt Ellerson
Journal:  AIDS Patient Care STDS       Date:  2010-04       Impact factor: 5.078

Review 5.  Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions.

Authors:  Elvin H Geng; Denis Nash; Andrew Kambugu; Yao Zhang; Paula Braitstein; Katerina A Christopoulos; Winnie Muyindike; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; Maya L Petersen; Jeffrey N Martin
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

6.  Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti.

Authors:  Edva Noel; Morgan Esperance; Megan McLaughlin; Rachel Bertrand; Jessy Devieux; Patrice Severe; Diessy Decome; Adias Marcelin; Janet Nicotera; Chris Delcher; Mark Griswold; Genevive Meredith; Jean William Pape; Serena P Koenig
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

7.  Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.

Authors:  Christopher J Hoffmann; James J Lewis; David W Dowdy; Katherine L Fielding; Alison D Grant; Neil A Martinson; Gavin J Churchyard; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

8.  Lost-to-care and engaged-in-care HIV patients in Leningrad Oblast, Russian Federation: barriers and facilitators to medical visit retention.

Authors:  Anna Pecoraro; Matthew J Mimiaga; Conall O'Cleirigh; Steven A Safren; Elena Blokhina; Elena Verbitskaya; Evgeny Krupitsky; Sergii Dvoriak; George Woody
Journal:  AIDS Care       Date:  2014-03-25

9.  "Just like fever": a qualitative study on the impact of antiretroviral provision on the normalisation of HIV in rural Tanzania and its implications for prevention.

Authors:  Maria Roura; Alison Wringe; Joanna Busza; Benjamin Nhandi; Doris Mbata; Basia Zaba; Mark Urassa
Journal:  BMC Int Health Hum Rights       Date:  2009-09-09

10.  From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania.

Authors:  Ray Nsigaye; Alison Wringe; Maria Roura; Samuel Kalluvya; Mark Urassa; Joanna Busza; Basia Zaba
Journal:  J Int AIDS Soc       Date:  2009-11-11       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.